Markets:

Overview

News

Currencies

International

Treasuries

C4 Therapeutics, Inc. - Common Stock (NQ:CCCC)

3.900 +0.030 (+0.78%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about C4 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

C4 Therapeutics Stock Is Surging Wednesday: What's Going On? ↗

December 13, 2023

C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading higher Wednesday after the company presented data from a Phase 1 trial for the p

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 13, 2023

Via Benzinga

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2023

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape...

Via Benzinga

D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Expert Ratings for C4 Therapeutics ↗

November 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 13, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!

Via InvestorPlace

C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma

December 12, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

Crude Oil Down 4%; Aditxt Shares Spike Higher ↗

December 12, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P...

Via Benzinga

Topics Stocks

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 12, 2023

Via Benzinga

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results ↗

December 12, 2023

U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&P...

Via Benzinga

Topics Stocks

Why Is Aditxt (ADTX) Stock Up 58% Today? ↗

December 12, 2023

Aditxt stock is up on Tuesday as investors in ADTX shares react to the company announcing plans to acquire Evofem Biosciences.

Via InvestorPlace

EGLE Stock Pops as Star Bulk Buys Eagle Bulk for $500 Million ↗

December 12, 2023

Eagle Bulk Shipping stock is climbing higher on Tuesday after EGLE investors learned of a merger agreement with Star Bulk Carriers.

Via InvestorPlace

Why Is C4 Therapeutics (CCCC) Stock Up 72% Today? ↗

December 12, 2023

C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.

Via InvestorPlace

US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November ↗

December 12, 2023

U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell...

Via Benzinga

Topics Economy Stocks

Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today? ↗

December 12, 2023

C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: MRK) to develop degrader-antibody conjugates (DACs), an emerging modality...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 12, 2023

Via Benzinga

C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs)

December 12, 2023

Initial Focus on One Oncology Target, Exclusive to Collaboration; Merck has Option for Three Additional Targets

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics to Host Webcast to Present New Dose Escalation Data from CFT7455 Phase 1 Study in Relapsed/Refractory Multiple Myeloma

November 28, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment

November 20, 2023

Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the Board of Directors

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 01, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 23, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 23, 2023

Via Benzinga

C4 Therapeutics Announces Upcoming Data Presentations for CFT8634, an Orally Bioavailable BiDAC™ Degrader in Development for Synovial Sarcoma and SMARCB1-Null Tumors, and CFT7455, an Orally Bioavailable MonoDAC™ Degrader in Development for Multiple

October 11, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Announces Chief Financial Officer Succession

September 05, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

August 08, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 17, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 06, 2023

Via Benzinga

Nasdaq Edges Lower Following Fed Minutes; C4 Therapeutics Shares Jump ↗

July 05, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.30% to 34,316.70 while the NASDAQ fell 0.04% to 13,811.43....

Via Benzinga

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.